Publication:
EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY.

Simple item page
dc.contributor.authorCalvo Gutierrez, J.
dc.contributor.authorLopez-Medina, C.
dc.contributor.authorAbalos-Aguilera, M. C.
dc.contributor.authorPerez Jimenez, A. B.
dc.contributor.authorRuiz-Vilchez, D.
dc.contributor.authorPilar, F. U.
dc.contributor.authorOrtega Castro, R.
dc.contributor.authorEscudero Contreras, A.
dc.contributor.authorCollantes Estevez, E.
dc.contributor.authoraffiliation[Calvo Gutierrez, J.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Medina, C.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Abalos-Aguilera, M. C.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Perez Jimenez, A. B.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Ruiz-Vilchez, D.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Pilar, F. U.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega Castro, R.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Escudero Contreras, A.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes Estevez, E.] Reina Sofia Univ Hosp, Cordoba, Spain
dc.contributor.authoraffiliation[Calvo Gutierrez, J.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Medina, C.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Abalos-Aguilera, M. C.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Perez Jimenez, A. B.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Ruiz-Vilchez, D.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Pilar, F. U.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega Castro, R.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Escudero Contreras, A.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes Estevez, E.] Maimonides Inst Res Biomed Cordoba IMIBIC, Cordoba, Spain
dc.contributor.authoraffiliation[Calvo Gutierrez, J.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Medina, C.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Abalos-Aguilera, M. C.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Perez Jimenez, A. B.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Ruiz-Vilchez, D.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Pilar, F. U.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega Castro, R.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Escudero Contreras, A.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes Estevez, E.] Cordoba Univ UCO, Dept Rheumatol, Cordoba, Spain
dc.date.accessioned2023-05-03T13:30:48Z
dc.date.available2023-05-03T13:30:48Z
dc.date.issued2022-06-01
dc.description.abstractIn the current situation of the SARS-CoV-2 pandemic, the Spanish Society of Rheumatology recommends vaccination of patients with chronic inflammatory diseases (CID) under treatment with biological DMARDs (bDMARDs). However, the data regarding the generation of protective antibody titers after mRNA vaccines in patients with CID is limited.
dc.identifier.citationGutierrez JC, López-Medina C, Ábalos-Aguilera MC, Jiménez ABP, Ruíz-Vilchez D, Pilar FU, et al. AB1149 EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):1691.2-1692.
dc.identifier.doi10.1136/annrheumdis-2022-eular.3926
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/81/Suppl_1/1691.2.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20109
dc.identifier.wosID850279007088
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number1691-1692
dc.publisherBmj publishing group
dc.relation.publisherversionhttps://ard.bmj.com/content/81/Suppl_1/1691.2.abstract
dc.rights.accessRightsopen access
dc.subject.decsAntirreumáticos
dc.subject.decsPandemias
dc.subject.decsReumatología
dc.subject.decsTratamiento insuficiente
dc.subject.decsVacunas de ARNm
dc.subject.meshSARS-CoV-2
dc.subject.meshmRNA vaccines
dc.subject.meshPandemics
dc.subject.meshRheumatology
dc.subject.meshUndertreatment
dc.subject.meshVaccination
dc.subject.meshAntirheumatic agents
dc.titleEVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY.
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number81
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Calvo_EvaluationOf.pdf
Size:
322 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía